These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20231188)

  • 21. Asymptomatic bacteriuria in pregnant mothers: a valid and cost-effective screening test in Bangladesh.
    Ullah A; Barman A; Ahmed I; Salam A
    J Obstet Gynaecol; 2012 Jan; 32(1):37-41. PubMed ID: 22185534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenging chronic kidney disease: experience from chronic kidney disease prevention programs in Shanghai, Japan, Taiwan and Australia.
    Chen N; Hsu CC; Yamagata K; Langham R
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():31-6. PubMed ID: 20586945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipstick chemical urinalysis: an accurate cost-effective screening test.
    Mariani AJ; Luangphinith S; Loo S; Scottolini A; Hodges CV
    J Urol; 1984 Jul; 132(1):64-6. PubMed ID: 6427486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients.
    Le Floch JP; Charles MA; Philippon C; Perlemuter L
    Diabet Med; 1994 May; 11(4):349-56. PubMed ID: 8088106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipstick pseudohematuria: unnecessary consultation and evaluation.
    Rao PK; Gao T; Pohl M; Jones JS
    J Urol; 2010 Feb; 183(2):560-4. PubMed ID: 20018314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diagnosis of Urinary Tract Infection in Young Children (DUTY) Study Clinical Rule: Economic Evaluation.
    Hollingworth W; Busby J; Butler CC; O'Brien K; Sterne JA; Hood K; Little P; Lawton M; Birnie K; Thomas-Jones E; Harman K; Hay AD;
    Value Health; 2017 Apr; 20(4):556-566. PubMed ID: 28407997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of mass screening for dipstick hematuria in Japan.
    Okubo R; Hoshi SL; Kimura T; Kondo M; Asahi K; Iseki C; Fujimoto S; Narita I; Nishiyama H; Yamagata K; Iseki K
    Clin Exp Nephrol; 2022 May; 26(5):398-412. PubMed ID: 35000032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility study of the early detection and treatment of renal disease by mass screening.
    Craig JC; Barratt A; Cumming R; Irwig L; Salkeld G
    Intern Med J; 2002; 32(1-2):6-14. PubMed ID: 11783681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of underlying causes in asymptomatic, early-stage renal diseases by dipstick test.
    Okur M; Arslan S; Sami Guven A; Temel H; Selcuk Bektas M; Ustyol L
    Med Glas (Zenica); 2013 Feb; 10(1):55-8. PubMed ID: 23348162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipstick only urinalysis screen for the pediatric emergency room.
    Craver RD; Abermanis JG
    Pediatr Nephrol; 1997 Jun; 11(3):331-3. PubMed ID: 9203184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-Effectiveness of School Urinary Screening for Early Detection of IgA Nephropathy in Japan.
    Honda K; Akune Y; Goto R
    JAMA Netw Open; 2024 Feb; 7(2):e2356412. PubMed ID: 38363568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic implications of three strategies for the control of taeniasis.
    Alexander A; John KR; Jayaraman T; Oommen A; Venkata Raghava M; Dorny P; Rajshekhar V
    Trop Med Int Health; 2011 Nov; 16(11):1410-6. PubMed ID: 21790912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of chronic kidney disease mass screening test in Japan.
    Kondo M; Yamagata K; Hoshi SL; Saito C; Asahi K; Moriyama T; Tsuruya K; Yoshida H; Iseki K; Watanabe T
    Clin Exp Nephrol; 2012 Apr; 16(2):279-91. PubMed ID: 22167460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the cost of developmental and behavioral screening of preschool children in general pediatric practice.
    Dobrez D; Sasso AL; Holl J; Shalowitz M; Leon S; Budetti P
    Pediatrics; 2001 Oct; 108(4):913-22. PubMed ID: 11581444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The compliance and cost-effectiveness of smartphone urinalysis albumin screening for people with diabetes in England.
    Shore J; Green M; Hardy A; Livesey D
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):387-395. PubMed ID: 31354065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine dipstick vs. microscopic urinalysis in the evaluation of abdominal trauma.
    Kennedy TJ; McConnell JD; Thal ER
    J Trauma; 1988 May; 28(5):615-7. PubMed ID: 3367403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional variance in the use of urine dipstick test for outpatients in Japan.
    Nishi H; Yoshida Y; Inoue R; Takemura K; Nangaku M
    Nephrology (Carlton); 2020 Sep; 25(9):676-682. PubMed ID: 32243023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combining the use of dipstick protein and specific gravity accurately predicts pathological proteinuria in Japan].
    Endo T; Komiya T; Yonemoto S; Tsukamoto T; Fujikawa J; Muso E
    Nihon Jinzo Gakkai Shi; 2008; 50(7):934-41. PubMed ID: 19069152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to use… urine dipsticks.
    Cyriac J; Holden K; Tullus K
    Arch Dis Child Educ Pract Ed; 2017 Jun; 102(3):148-154. PubMed ID: 27836919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.